Clinical Trial

A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants

Name: A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants — clinical trial record (NCT07727538)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary purpose of the study is to evaluate the efficacy of olezarsen administered by subcutaneous injection to pediatric participants with FCS.

Trial Details

NCT Number	NCT07727538
Lead Sponsor	Ionis Pharmaceuticals, Inc.
Conditions	Familial Chylomicronemia Syndrome
Enrollment	12 participants
Start Date	2026-07
Primary Completion	2030-08 (estimated)
Study Completion	2031-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-29